NEW ORLEANS, Oct. 17, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 23, 2017 to file lead plaintiff applications in a securities class action lawsuit against Top Ships Inc. (Nasdaq:TOPS), if they purchased the Company’s shares between January 17, 2017 and August 22, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Top Ships investors should visit us at https://www.claimsfiler.com/cases/view-top-ships-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Top Ships and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
Throughout 2017, Top Ships engaged in a stock scheme of selling tens of millions of its shares to Kalani Investments Limited at a deeply discounted rate and then filing registration statements enabling Kalani to resell the shares. As the selloff caused the share price to decline, Top Ships would then artificially raise the price via a reverse stock split, causing shares to be merged.
As a result of this scheme, the price of Top Ships’ shares has plummeted by more than 99%.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 



